2024年6月最新影响因子数据已经更新，欢迎查询！ 如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | EUROPEAN UROLOGY EUR UROL （此期刊被最新的JCR期刊SCIE收录） LetPub评分 9.4
52人评分
我要评分
声誉 9.9 影响力 9.4 速度 7.1 | |||||||||||||||||||||
| 期刊ISSN | 0302-2838 | 微信扫码收藏此期刊 | ||||||||||||||||||||
| E-ISSN | 1421-993X | |||||||||||||||||||||
| 2023-2024最新影响因子 （数据来源于搜索引擎） | 25.3 点击查看影响因子趋势图 | |||||||||||||||||||||
| 实时影响因子 | 截止2024年10月29日：17.316 | |||||||||||||||||||||
| 2023-2024自引率 | 2.80%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年影响因子 | 19.4 | |||||||||||||||||||||
| JCI期刊引文指标 | 6.66 | |||||||||||||||||||||
| h-index | 187 | |||||||||||||||||||||
| CiteScore （ 2024年最新版） |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | http://www.europeanurology.com/ | |||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/EURUROL | |||||||||||||||||||||
| 期刊语言要求 | Language Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service. 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足EUROPEAN UROLOGY的语言要求，还能让EUROPEAN UROLOGY编辑和审稿人得到更好的审稿体验，让稿件最大限度地被EUROPEAN UROLOGY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||
| 通讯方式 | ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE | |||||||||||||||||||||
| 出版商 | Elsevier | |||||||||||||||||||||
| 涉及的研究方向 | 医学-泌尿学与肾脏学 | |||||||||||||||||||||
| 出版国家或地区 | NETHERLANDS | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||||||
| 出版年份 | 1975 | |||||||||||||||||||||
| 年文章数 | 93点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 35.55% | |||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 79.57% | |||||||||||||||||||||
| WOS期刊SCI分区 （ 2023-2024年最新版） | WOS分区等级：1区
| |||||||||||||||||||||
| 中国科学院《国际期刊预警 名单（试行）》名单 | 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||
| 中国科学院SCI期刊分区 （ 2023年12月最新升级版） | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||
| 中国科学院SCI期刊分区 （ 2022年12月升级版） |
| |||||||||||||||||||||
| 中国科学院SCI期刊分区 （ 2021年12月旧的升级版） |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0302-2838%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 一般,3-6周 来源Elsevier官网： 平均3周 | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 很难 | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在EUROPEAN UROLOGY顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 | |||||||||||||||||||||
| 在线出版周期 | 来源Elsevier官网： 平均21.8周 | |||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Genomic Profiling and Response to Immune Checkpoint Inhibition plus Tyrosine Kinase Inhibition in FH-Deficient Renal Cell Carcinoma Author: Xu, Yunze; Kong, Wen; Cao, Ming; Wang, Jieying; Wang, Zaoyu; Zheng, Liang; Wu, Xiaoyu; Cheng, Rongrong; He, Wei; Yang, Bo; Dong, Baijun; Pan, Jiahua; Chen, Yonghui; Huang, Jiwei; Jiang, Chen; Zhai, Wei; Li, Fangzhou; Chen, Ruohua; Zhou, Xiang; Wu, Guangyu; Geng, Xiaochuan; Chen, Jiasheng; An, Huimin; Yuan, Yichu; Xu, Tianyuan; Chen, Dongning; Lin, Dengqiang; Xu, Lieyu; Huang, Kangbo; Peng, Ling; Yu, Yanfei; Tai, Shengcheng; Qi, Honggang; Luo, Kai; Kang, Xiaonan; Wang, Hang; Huang, Yiran; Zhang, Jin; Xue, Wei Journal: EUROPEAN UROLOGY. 2023; Vol. 83, Issue 2, pp. 163-172. DOI: 10.1016/j.eururo.2022.05.029 PubMed DOI |
| 2. | Re: Alberto Briganti, Nicola Fossati, James W.F. Catto, et al. Active Surveillance for Low-risk Prostate Cancer: The European Association of Urology Position in 2018. Eur Urol 2018;74:357–68 Author: Yongbao Wei, Tao Li, Longfei Liu Journal: EUROPEAN UROLOGY, 2018, Vol., , DOI:10.1016/j.eururo.2018.12.013 DOI |
| 3. | The Long Noncoding RNA TTTY15, Which Is Located on the Y Chromosome, Promotes Prostate Cancer Progression by Sponging let-7 Author: Guang’an Xiao, Jingjing Yao, Depei Kong, Chen Ye, Rui Chen, Li Li, Tao Zeng, Liujun Wang, Wei Zhang, Xiaolei Shi, Tie Zhou, Jing Li, Yue Wang, Chuan Liang Xu, Junfeng Jiang, Yinghao Sun Journal: EUROPEAN UROLOGY, 2018, Vol., , DOI:10.1016/j.eururo.2018.11.012 DOI |
| 4. | Reply to Pontus Eriksson and Gottfrid Sjödahl's Letter to the Editor re: Tuan Zea Tan, Mathieu Rouanne, Kien Thiam Tan, Ruby Yun-Ju Huang, Jean-Paul Thiery. Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2018.08.027 Author: Tuan Zea Tan, Mathieu Rouanne, Ruby Yun-Ju Huang, Jean-Paul Thiery Journal: EUROPEAN UROLOGY, 2018, Vol., , DOI:10.1016/j.eururo.2018.11.048 DOI |
| 5. | Re: Stephanie Guillaumier, Max Peters, Manit Arya, et al. A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer. Eur Urol 2018;74:422–9 Author: Zhien Zhou, Yi Zhou, Weigang Yan Journal: EUROPEAN UROLOGY, 2018, Vol., , DOI:10.1016/j.eururo.2018.11.036 DOI |
| 6. | Re: Guido Giusti, Silvia Proietti, Moises E. Rodríguez-Socarrás, et al. Simultaneous Bilateral Endoscopic Surgery (SBES) for Patients with Bilateral Upper Tract Urolithiasis: Technique and Outcomes. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2018.06.034 Author: Jie Gu, Dongjie Li, Xiaobo Zhang Journal: EUROPEAN UROLOGY, 2018, Vol., , DOI:10.1016/j.eururo.2018.11.019 DOI |
| 7. | A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian Settings Author: Peter K.-F. Chiu, Chi-Fai Ng, Axel Semjonow, Yao Zhu, Sébastien Vincendeau, Alain Houlgatte, Massimo Lazzeri, Giorgio Guazzoni, Carsten Stephan, Alexander Haese, Ilse Bruijne, Jeremy Yuen-Chun Teoh, Chi Ho Leung, Paola Casale, Chih Hung Chiang, Lincoln Guan-Lim Tan, Edmund Chiong, Chao Yuan Huang, Hsi Chin Wu, Daan Nieboer, Ding-Wei Ye, Chris H. Bangma, Monique J. Roobol Journal: EUROPEAN UROLOGY, 2018, Vol., , DOI:10.1016/j.eururo.2018.10.047 DOI |
| 8. | Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion Author: Qiang Fu, Le Xu, Yiwei Wang, Qi Jiang, Zheng Liu, Junyu Zhang, Quan Zhou, Han Zeng, Shanyou Tong, Tao Wang, Yangyang Qi, Baoying Hu, Hangcheng Fu, Huyang Xie, Lin Zhou, Yuan Chang, Yu Zhu, Bo Dai, Weijuan Zhang, Jiejie Xu Journal: EUROPEAN UROLOGY, 2018, Vol., , DOI:10.1016/j.eururo.2018.09.030 DOI |
| 9. | Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9® to Suppress Enzalutamide-resistant Prostate Cancer Progression Author: Ronghao Wang, Yin Sun, Lei Li, Yuanjie Niu, Wanying Lin, Changyi Lin, Emmanuel S. Antonarakis, Jun Luo, Shuyuan Yeh, Chawnshang Chang Journal: EUROPEAN UROLOGY, 2017, Vol.72, 835-844, DOI:10.1016/j.eururo.2017.04.005 DOI |
| 10. | Re: Archie Fernando, James Pattison, Catherine Horsfield, David D’Cruz, Gary Cook, Tim O’Brien. [18F]-Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis, Treatment Stratification, and Monitoring of Patients with Retroperitoneal Fibrosis: A Prospective Clinical Study. Eur Urol 2017;71:926–33 Author: Liangyou Gu, Yiwen Wang, Xu Zhang Journal: EUROPEAN UROLOGY, 2017, Vol.72, e43-e44, DOI:10.1016/j.eururo.2017.02.029 DOI |
|
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
